Parkman Healthcare Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5M | Sell |
488,796
-273,825
| -36% | -$7.58M | 1.55% | 21 |
|
|
2025
Q1 | $16.9M | Sell |
762,621
-2,832
| -0.4% | -$62.9K | 2.01% | 16 |
|
|
2024
Q4 | $15.1M | Buy |
765,453
+10,209
| +1% | +$202K | 2.02% | 16 |
|
|
2024
Q3 | $18.9M | Buy |
755,244
+108,102
| +17% | +$2.7M | 2.41% | 9 |
|
|
2024
Q2 | $12.1M | Buy |
647,142
+979
| +0.2% | +$18.3K | 1.62% | 20 |
|
|
2024
Q1 | $12.7M | Buy |
646,163
+30,470
| +5% | +$601K | 1.56% | 20 |
|
|
2023
Q4 | $10.8M | Buy |
615,693
+105,883
| +21% | +$1.86M | 1.52% | 21 |
|
|
2023
Q3 | $8.86M | Buy |
509,810
+218,107
| +75% | +$3.79M | 1.62% | 16 |
|
|
2023
Q2 | $4.11M | Buy |
291,703
+41,446
| +17% | +$584K | 0.71% | 44 |
|
|
2023
Q1 | $2.69M | Buy |
250,257
+58,950
| +31% | +$634K | 0.59% | 50 |
|
|
2022
Q4 | $2.87M | Buy |
191,307
+65,115
| +52% | +$975K | 0.76% | 47 |
|
|
2022
Q3 | $1.62M | Buy |
126,192
+1,484
| +1% | +$19.1K | 0.46% | 64 |
|
|
2022
Q2 | $1.21M | Buy |
124,708
+6,461
| +5% | +$62.6K | 0.44% | 56 |
|
|
2022
Q1 | $1.18M | Buy |
118,247
+4,603
| +4% | +$45.7K | 0.34% | 64 |
|
|
2021
Q4 | $1.34M | Buy |
+113,644
| New | +$1.34M | 0.3% | 67 |
|
|
2021
Q2 | – | Sell |
-80,603
| Closed | -$1.49M | – | 91 |
|
|
2021
Q1 | $1.49M | Buy |
80,603
+5,603
| +7% | +$104K | 0.35% | 65 |
|
|
2020
Q4 | $1.33M | Buy |
+75,000
| New | +$1.33M | 0.34% | 70 |
|